MedPath

TO COMPARE THE WEIGHT LOSS BETWEEN BANDED GASTRIC BYPASS PATIENTS AND NON BANDED GASTRIC BYPASS PATIENTS.BANDED GASTRIC BYPASS IS MEANT TO BE AN APPLICATION OF SILICONE BAND/RING AROUND THE STOMACH POUCH THAT IS CREATED INTRAOPERATIVELY FROM A PROPORTION OF PART OF STOMACH

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2022/05/042634
Lead Sponsor
Dept of surgical Disciplines AIIMS New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Patients with morbid obesity, defined as Body Mass Index (BMI) > 37.5kg/m2.

2)Patients with BMI > 32.5 kg/m2 with obesity related co-morbidities.

3)Patients who have failed to maintain weight loss after trying appropriate non-surgical measures.

4)Patients who have comprehension and commitment to long term follow up.

5)Patients who gave consent for the study.

6)Age >18, & < 65

Exclusion Criteria

1)Any contraindication for bariatric surgery

There are no absolute contraindications for bariatric surgery.

Relative contraindications are:

-severe heart failure

-unstable coronary artery disease

-end-stage lung disease

-active cancer treatment

-portal hypertension

-drug/alcohol dependency

-impaired intellectual capacity

2)Patients requiring revision gastric bypass.

3)Refusal to participate in the study.

4)Ageless than18 & more than 65 years.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the mean percentage of excess weight loss (% EWL) at the end of 6 months & 1 year follow up period between patients who underwent banded Gastric bypass with non-banded gastric bypass procedures.Timepoint: At the end of 6 months & 1 year follow-up period.
Secondary Outcome Measures
NameTimeMethod
i.To compare the following for: <br/ ><br> 1.Mean OT time. <br/ ><br> 2.Mean length of hospital <br/ ><br> stay. <br/ ><br> 3.Incidence of <br/ ><br> complications, between <br/ ><br> the two procedures. <br/ ><br> 4.The impact of <br/ ><br> comorbidities (Diabetes <br/ ><br> Mellitus, Hypertension, <br/ ><br> Obstructive Sleep Apnea, <br/ ><br> Gastro-esophageal reflux <br/ ><br> disease, Dyslipidemia, <br/ ><br> Hypothyroidism) between <br/ ><br> the two types of <br/ ><br> procedures. <br/ ><br> 5.The quality of life <br/ ><br> (BAROS) score, GI quality <br/ ><br> of life score (GIQLI). <br/ ><br>Timepoint: At the end of 6 months & 1 year follow-up period.
© Copyright 2025. All Rights Reserved by MedPath